Shanghai Allist Pharmaceuticals Co., Ltd. (SHA: 688578)
China
· Delayed Price · Currency is CNY 58.93
-0.27 (-0.46%)
Jan 3, 2025, 3:00 PM CST
Shanghai Allist Pharmaceuticals Revenue
Shanghai Allist Pharmaceuticals had revenue of 957.00M CNY in the quarter ending September 30, 2024, with 59.73% growth. This brings the company's revenue in the last twelve months to 3.20B, up 97.64% year-over-year. In the year 2023, Shanghai Allist Pharmaceuticals had annual revenue of 2.02B with 155.14% growth.
Revenue (ttm)
3.20B
Revenue Growth
+97.64%
P/S Ratio
8.28
Revenue / Employee
3.07M
Employees
1,044
Market Cap
26.52B
Revenue Chart
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Shenzhen Mindray Bio-Medical Electronics | 37.11B |
| Jiangsu Hengrui Medicine | 26.00B |
| WuXi AppTec | 38.50B |
| Zhangzhou Pientzehuang Pharmaceutical., | 10.91B |
| Aier Eye Hospital Group | 20.62B |
| Shanghai United Imaging Healthcare | 10.93B |
| Yunnan Baiyao Group Co.,Ltd | 39.34B |
| Beijing Wantai Biological Pharmacy Enterprise | 2.49B |